Endometriosis, a debilitating condition affecting millions of women worldwide, has long been associated with a range of symptoms and complications. A recent study published in Human Reproduction has shed new light on the progression of this disease, revealing a surprising pattern that could have significant implications for diagnosis, treatment, and patient management. The research, conducted over a 12-year period, analyzed data from over 14,000 patients across seven countries, providing a comprehensive understanding of how endometriosis evolves over time.
One of the key findings of the study was the observation that endometriosis progression appears to plateau in the early 30s. Specifically, the odds of superficial endometriosis decreased by 3% each year, while deep lesions continued to increase at varying rates across different anatomical sites. This suggests that the disease may reach a natural stopping point in its progression around the age of 30 to 33 years.
The study also revealed that older patients had more deep lesions and ovarian endometriomas at the time of laparoscopy, with the total number of affected sites increasing by 0.12 sites per year. However, this increase stopped after age 32.8 years. Interestingly, the prevalence of bowel lesions and uterosacral ligament lesions increased by 7% and 4% per year, respectively, until about 33 years of age, while deep pelvic sidewall lesions increased by 7% each year until about 31 years of age. After these ages, the prevalence stopped increasing.
Bladder endometriosis exhibited a different behavior, increasing by 12% per year until about 28 years of age, followed by a decrease of 2% each year. Ovarian endometriomas continued to increase rapidly early on, with a peak prevalence at around 41 years of age. Overall, the study found that endometriosis lesions tended to become deeper, involve more sites, and include ovarian endometriomas as patients aged, but the progression largely flattened out after age 30.
Dr. Tal Jacobson, a senior staff specialist in obstetrics and gynaecology, described the paper as "powerful." He noted that the study implies a progression of more severe endometriosis with age, which is an intuitive thought. However, the study also suggests that the peak of this progression occurs quite early, at around 30 years of age, which was surprising to Dr. Jacobson. He emphasized the importance of understanding the natural history and progression of endometriosis, as it can provide valuable insights into the disease's development and management.
Despite the study's comprehensive nature, Dr. Jacobson pointed out some significant restrictions in interpreting the findings. The study only included patients who had undergone a specific surgical procedure, which may not represent the broader population of endometriosis patients. Additionally, the research did not provide outcomes such as fertility, pain, or repeat surgery, nor did it include information on whether patients had tried medical therapy to suppress the disease. Dr. Jacobson emphasized that the study cannot provide reassurance, as fertility starts to decline significantly at age 35, and the "peak endo" is also associated with the start of this decline.
From a symptomatic point of view, the plateau in endometriosis progression does not necessarily mean that the disease suddenly stops getting worse in the early 30s. Dr. Jacobson explained that endometriosis often continues to cause pain and other symptoms, and the disease may even be exacerbated by the use of hormone replacement therapy (HRT) in postmenopausal women. He highlighted the need for further discussion and research on the relationship between endometriosis and menopause, as the use of HRT has increased significantly in recent years.
In conclusion, the study's findings suggest that endometriosis progression may reach a natural stopping point in the early 30s, but the disease can still cause significant symptoms and complications in older patients. The research highlights the importance of understanding the natural history and progression of endometriosis, as well as the need for further investigation into the relationship between the disease and menopause. These insights can help guide clinical decision-making and improve patient outcomes for women affected by this debilitating condition.
